Dianthus Therapeutics, Inc. /DE/ - DNTH
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Apr 01, 2026 | EVP, CFO & CBO | M | D | 40,000.0 | 0.0 | 0.0 | 80,000.0 | View | |
| Apr 01, 2026 | EVP, CFO & CBO | M | D | 74,367.0 | 0.0 | 0.0 | 10,399.0 | View | |
| Apr 01, 2026 | EVP, CFO & CBO | S | D | 7,232.0 | 85.54 | 618,625.28 | 0.0 | View | |
| Apr 01, 2026 | EVP, CFO & CBO | S | D | 19,469.0 | 84.57 | 1,646,493.33 | 7,232.0 | View | |
| Apr 01, 2026 | EVP, CFO & CBO | S | D | 59,800.0 | 83.9 | 5,017,220.0 | 26,701.0 | View | |
| Apr 01, 2026 | EVP, CFO & CBO | S | D | 2,366.0 | 82.84 | 195,999.44 | 86,501.0 | View | |
| Apr 01, 2026 | EVP, CFO & CBO | S | D | 800.0 | 81.36 | 65,088.0 | 88,867.0 | View | |
| Apr 01, 2026 | EVP, CFO & CBO | S | D | 1,485.0 | 80.25 | 119,171.25 | 89,667.0 | View | |
| Apr 01, 2026 | EVP, CFO & CBO | S | D | 21,825.0 | 78.86 | 1,721,119.5 | 91,152.0 | View | |
| Apr 01, 2026 | EVP, CFO & CBO | S | D | 1,390.0 | 78.33 | 108,878.7 | 112,977.0 | View | |
| Apr 01, 2026 | EVP, CFO & CBO | M | A | 40,000.0 | 17.88 | 715,200.0 | 114,367.0 | View | |
| Apr 01, 2026 | EVP, CFO & CBO | M | A | 74,367.0 | 8.44 | 627,657.48 | 74,367.0 | View | |
| Apr 01, 2026 | — | M | D | 599.0 | 0.0 | 0.0 | 599.0 | View | |
| Apr 01, 2026 | — | S | D | 599.0 | 80.11 | 47,985.89 | 0.0 | View | |
| Apr 01, 2026 | — | M | A | 599.0 | 8.44 | 5,055.56 | 599.0 | View | |
| Mar 26, 2026 | — | M | D | 27,594.0 | 0.0 | 0.0 | 1,198.0 | View | |
| Mar 26, 2026 | — | S | D | 27,594.0 | 78.05 | 2,153,711.7 | 0.0 | View | |
| Mar 26, 2026 | — | M | A | 27,594.0 | 8.44 | 232,893.36 | 27,594.0 | View | |
| Mar 17, 2026 | CEO AND PRESIDENT | M | D | 5,592.0 | 0.0 | 0.0 | 269,408.0 | View | |
| Mar 17, 2026 | CEO AND PRESIDENT | M | D | 59,700.0 | 0.0 | 0.0 | 41.0 | View | |
| Mar 17, 2026 | CEO AND PRESIDENT | M | A | 5,592.0 | 17.88 | 99,984.96 | 65,292.0 | View | |
| Mar 17, 2026 | CEO AND PRESIDENT | M | A | 59,700.0 | 6.7 | 399,990.0 | 59,700.0 | View | |
| Mar 13, 2026 | CHIEF ACCOUNTING OFFICER | M | D | 10,000.0 | 0.0 | 0.0 | 50,000.0 | View | |
| Mar 13, 2026 | CHIEF ACCOUNTING OFFICER | M | D | 17,500.0 | 0.0 | 0.0 | 42,500.0 | View | |
| Mar 13, 2026 | CHIEF ACCOUNTING OFFICER | M | D | 16,182.0 | 0.0 | 0.0 | 63,818.0 | View | |
| Mar 13, 2026 | CHIEF ACCOUNTING OFFICER | S | D | 300.0 | 85.53 | 25,659.0 | 0.0 | View | |
| Mar 13, 2026 | CHIEF ACCOUNTING OFFICER | S | D | 200.0 | 83.38 | 16,676.0 | 300.0 | View | |
| Mar 13, 2026 | CHIEF ACCOUNTING OFFICER | S | D | 3,865.0 | 82.66 | 319,480.9 | 500.0 | View | |
| Mar 13, 2026 | CHIEF ACCOUNTING OFFICER | S | D | 23,465.0 | 81.75 | 1,918,263.75 | 4,365.0 | View | |
| Mar 13, 2026 | CHIEF ACCOUNTING OFFICER | S | D | 15,852.0 | 80.71 | 1,279,414.92 | 27,830.0 | View | |
| Mar 13, 2026 | CHIEF ACCOUNTING OFFICER | M | A | 10,000.0 | 21.77 | 217,700.0 | 43,682.0 | View | |
| Mar 13, 2026 | CHIEF ACCOUNTING OFFICER | M | A | 17,500.0 | 22.07 | 386,225.0 | 33,682.0 | View | |
| Mar 13, 2026 | CHIEF ACCOUNTING OFFICER | M | A | 16,182.0 | 17.88 | 289,334.16 | 16,182.0 | View | |
| Mar 13, 2026 | CEO AND PRESIDENT | M | D | 122,918.0 | 0.0 | 0.0 | 59,741.0 | View | |
| Mar 13, 2026 | CEO AND PRESIDENT | S | D | 900.0 | 85.53 | 76,977.0 | 0.0 | View | |
| Mar 13, 2026 | CEO AND PRESIDENT | S | D | 200.0 | 83.38 | 16,676.0 | 900.0 | View | |
| Mar 13, 2026 | CEO AND PRESIDENT | S | D | 12,796.0 | 82.6 | 1,056,949.6 | 1,100.0 | View | |
| Mar 13, 2026 | CEO AND PRESIDENT | S | D | 65,517.0 | 81.74 | 5,355,359.58 | 13,896.0 | View | |
| Mar 13, 2026 | CEO AND PRESIDENT | S | D | 43,505.0 | 80.69 | 3,510,418.45 | 79,413.0 | View | |
| Mar 13, 2026 | CEO AND PRESIDENT | M | A | 122,918.0 | 6.7 | 823,550.6 | 122,918.0 | View | |
| Mar 13, 2026 | EVP, Head of R&D | M | D | 12,500.0 | 0.0 | 0.0 | 106,250.0 | View | |
| Mar 13, 2026 | EVP, Head of R&D | M | D | 8,332.0 | 0.0 | 0.0 | 54,174.0 | View | |
| Mar 13, 2026 | EVP, Head of R&D | M | D | 5,000.0 | 0.0 | 0.0 | 71,184.0 | View | |
| Mar 13, 2026 | EVP, Head of R&D | M | D | 7,998.0 | 0.0 | 0.0 | 3,998.0 | View | |
| Mar 13, 2026 | EVP, Head of R&D | S | D | 33,830.0 | 81.48 | 2,756,468.4 | 0.0 | View | |
| Mar 13, 2026 | EVP, Head of R&D | M | A | 12,500.0 | 22.07 | 275,875.0 | 33,830.0 | View | |
| Mar 13, 2026 | EVP, Head of R&D | M | A | 8,332.0 | 21.77 | 181,387.64 | 21,330.0 | View | |
| Mar 13, 2026 | EVP, Head of R&D | M | A | 5,000.0 | 17.88 | 89,400.0 | 12,998.0 | View | |
| Mar 13, 2026 | EVP, Head of R&D | M | A | 7,998.0 | 8.44 | 67,503.12 | 7,998.0 | View | |
| Feb 04, 2026 | EVP, CFO & CBO | A | A | 150,000.0 | 0.0 | 0.0 | 150,000.0 | View | |
| Feb 04, 2026 | CEO AND PRESIDENT | A | A | 355,000.0 | 0.0 | 0.0 | 355,000.0 | View | |
| Feb 04, 2026 | CHIEF ACCOUNTING OFFICER | A | A | 55,000.0 | 0.0 | 0.0 | 55,000.0 | View | |
| Feb 04, 2026 | EVP, Head of R&D | A | A | 150,000.0 | 0.0 | 0.0 | 150,000.0 | View | |
| Feb 04, 2026 | SVP, General Counsel and Sec. | A | A | 100,000.0 | 0.0 | 0.0 | 100,000.0 | View | |
| Dec 05, 2025 | CFO & CBO | M | A | 20,000.0 | 0.0 | 0.0 | 84,766.0 | View | |
| Dec 05, 2025 | CFO & CBO | S | D | 20,000.0 | 45.18 | 903,600.0 | 0.0 | View | |
| Dec 05, 2025 | CFO & CBO | M | A | 20,000.0 | 8.44 | 168,800.0 | 20,000.0 | View | |
| Nov 14, 2025 | EVP, Head of R&D | M | D | 31,250.0 | 0.0 | 0.0 | 118,750.0 | View | |
| Nov 14, 2025 | EVP, Head of R&D | M | D | 37,494.0 | 0.0 | 0.0 | 62,506.0 | View | |
| Nov 14, 2025 | EVP, Head of R&D | M | D | 40,287.0 | 0.0 | 0.0 | 76,184.0 | View | |
| Nov 14, 2025 | EVP, Head of R&D | M | D | 3,529.0 | 0.0 | 0.0 | 116,471.0 | View | |
| Nov 14, 2025 | EVP, Head of R&D | M | D | 83,978.0 | 0.0 | 0.0 | 11,996.0 | View | |
| Nov 14, 2025 | EVP, Head of R&D | S | D | 109,031.0 | 38.14 | 4,158,442.34 | 4,000.0 | View | |
| Nov 14, 2025 | EVP, Head of R&D | M | A | 31,250.0 | 22.07 | 689,687.5 | 113,031.0 | View | |
| Nov 14, 2025 | EVP, Head of R&D | M | A | 37,494.0 | 21.77 | 816,244.38 | 81,781.0 | View | |
| Nov 14, 2025 | EVP, Head of R&D | M | A | 40,287.0 | 17.88 | 720,331.56 | 44,287.0 | View | |
| Nov 14, 2025 | EVP, Head of R&D | S | D | 18,576.0 | 37.72 | 700,686.72 | 4,000.0 | View | |
| Nov 14, 2025 | EVP, Head of R&D | S | D | 42,765.0 | 37.04 | 1,584,015.6 | 22,576.0 | View | |
| Nov 14, 2025 | EVP, Head of R&D | S | D | 26,166.0 | 35.8 | 936,742.8 | 65,341.0 | View | |
| Nov 14, 2025 | EVP, Head of R&D | M | A | 3,529.0 | 17.88 | 63,098.52 | 91,507.0 | View | |
| Nov 14, 2025 | EVP, Head of R&D | M | A | 83,978.0 | 8.44 | 708,774.32 | 87,978.0 | View |